In addition, both univariate and multivariate analyses of the PKU-KIRC dataset showed that ccRCC patients expressing high levels of MTDH had a shorter overall survival (OS) and progression-free survival (PFS) than patients with low MTDH expression (Supplementary Tables 3 and 4). This evidence concerns the gene MTDH and nonpapillary renal cell carcinoma.